top of page

BIO

Personal Profile

David Grosman - Public Director

PROFESSIONAL EXPERIENCE

​​​

  • 03/2021- today external director, member of audit, balance and compensation committees, Saborit Ltd, Rehovot. The company is engaged in the development of a system for the production and printing of plant-based meat substitutes. The company is a company publicly traded on the Tel Aviv Stock Exchange (NYSE: SVRT.)

  • 12/2019-2/2022 (Currently: no active) - Partner and consultant, Chava Arava Research and Development Ltd, Hatzeva. The company develops topical products based on research and containing cannabinoids and plant extracts Various healers.

  • 1/2022 – today co-founder and business leader, Mechanics Robotics Ltd, Tzalim. Agritech is developing a unique automated production platform that will serve cannabis growers and other plants from the cuttings stage to the harvest stage.

  • 06/2018-2/2022 (Currently: no active) -Partner and consultant, Chava -Cannabis in Arava Ltd, Hatzeva. Has licenses under the regulations of the Ministry of Health for the propagation and cultivation of medical cannabis.  The company is in the midst of Establishment of the breeding complex.

  • 08/2017-07/2022 - Director, Gefen Investments Biomed Ltd, Herzliya. The holding company in the medical field and Tech Clean. The company is an Israeli public company which Traded on the Tel Aviv Stock Exchange (NYSE: GEFEN).

  • 01/2015-12/2019 (Until 2019 non-executive director dependent)- Chairman of the Board of Directors (as of 2019), Biomedico Hadrim Ltd. (formerly: Amnis Therapeutics Ltd.),Tel Aviv.  The company engaged in the fields of research and development, production, assembly and marketing of intended innovative products. For various medical uses in natural blood vessels in the heart, in venous bypasses in the heart, in blood vessels in the brain and in blood vessels other peripherals. The company is an Israeli public company that is traded on the Tel Aviv  Stock Exchange(Symbol): M.BIMC.

  • 02/2016-12/2018 -  Director (until 8/2018) and consultant, Beyond Air Inc (formerly AIT Therapeutics Inc.) New York and Nes Ziona. A company engaged in the development of treatments for infectious respiratory diseases based on Nitric Oxide. The company is American public company that is traded on NASDAQ (symbol: XAIR.

  • 11/2014-11/2017- External director, Select Biomed Ltd, Kfar Saba.
    A company engaged in the development of innovative and unique technology, which enables the selection of stem cells in biological filtration and merchandise. The company is an Israeli public company that is traded on NASDAQ (symbol: APOP).

  • 07/2007-16/2009 -  Chairman of the Board of Directors and CEO (as of 11/16) D-Pharm Ltd, Ramat Gan. My tenure began after the company failed a significant clinical trial in August 2016. During the period I examined transactions and companies for merger with the company. The company is an Israeli public company listed on the stock exchange for securities in Tel Aviv (NYSE: DPRM).

  • 01/2014-05/2016 -  Chairman of the Board, Algomizer Ltd, Petah Tikva. A company operating in the field of internet advertising software. The company is developing an algorithm that should help. For online businesses in recruiting new customers and increasing profits from existing customers. The company is a company. An Israeli public company that is traded on the Tel Aviv Stock Exchange (NYSE: ALMO).

  • 08/2011-08/2014 - External director and member of the audit committee, JFC Green Fields Capital Ltd. (formerly Rusta Green), Ramat Gan. The company sold all its business in the field of genetic improvement of seeds in March 2013 to the seed giant, Monsanto. Today the company is an investment company. The company is an Israeli public company that is traded at the Tel Aviv Stock Exchange (NYSE: GFC).

  • 02/2009-02/2014 - CEO and Director, XTL Biopharmaceuticals Ltd., Herzliya. The company is a drug development company in advanced stages (clinical trials) for the treatment of myeloma diseases common, schizophrenia and jaundice C. The company is an Israeli public company that is traded on NASDAQ (Symbol: XTLB) and at the Tel Aviv Stock Exchange (Symbol: XTL.)

  • 02/2009-02/2014 - CEO and Director, XTL Biopharmaceuticals Ltd., Herzliya. The company is a drug development company in advanced stages (clinical trials) for the treatment of myeloma diseases common, schizophrenia and jaundice C. The company is an Israeli public company that is traded on NASDAQ (Symbol: XTLB) and at the Tel Aviv Stock Exchange (Symbol: XTL.)

  • 07/2012-11/2013 - Director, Intercure Ltd,  Ra'anana. The company developed, produced, marketed and sold a medical device for the treatment of various diseases, especially blood pressure.The company is an Israeli public company that is traded on the Tel Aviv Stock Exchange (NYSE: INCR).

  • 11/2012-09/2013 - Director, Proteologics Ltd, Rehovot. The company was engaged in identifying drug targets in collaboration with Teva, Kline Smith Glaxo, etc. The technology on which the company operates is the result of the development of Nobel Prize winners Prof. Hershko and Prof. Chechenover. The company is an Israeli public company that is traded on the Tel Aviv Stock Exchange (symbol: PRTL).

  • 01/2009-04/2011 - Director, Biolight Investments in Life Sciences in Israel Ltd., Ramat Gan. The company invests in companies in various fields in the life sciences and medicine (focusing on diagnostics and in ophthalmology). The company is an Israeli public company that is traded on the Tel Aviv Stock Exchange Spring (symbol: BOLT).

  • 05/2007-07/2008 - Director and member of the audit committee, Gilat Satcom, Petah Tikva. The company operating as an international service provider that provides satellite bandwidth and mobile data communication services, Customers operating in the area lack physical infrastructure. The company was an Israeli public company traded on AIM.

  • 03/2006-01/2009 -  Vice President of Investments, Eurocom Investments, Ramat Gan (the investment arm of the Eurocom Group). Limited partnership which functions as an active Private Equity fund that invests and manages its holdings in companies, mainly public, long-term and manages the group's treasury in financial activity. At that time, a skeleton in Boursai with a cash fund of NIS 28 million. The company is a public company Vice President of Investments, Sahar Investments Ltd. (now Enlight Energy), Ramat Gan. An Israeli company traded in Tel Aviv (NYSE: ENLT).

  • 07/2003-03/2006 -  senior analyst, Israel HealthCare Ventures (IHCV), Tel Aviv. A leading venture capital fund specializing in investments in the field of life sciences. Deal flow management and contact with companies.

  • 11/2001-03/2003 - Senior investment banker, Reliance Capital, Tel Aviv. The company operated both as an investment company and as an investment bank.

  • 11/1996-11/2001 - Partner, Magna Business Development, Herzliya. A family-owned business consulting company. The company is mainly engaged in the development of marketing and sales infrastructures for technology products in the world, and is focused on medical equipment and devices as well as capital equipment for industry.

​

MILITARY SERVICE

  • 11/1993-01/1996 - Voluntary abbreviated service (temporarily lowering profile due to a car accident) at the Air Force Headquarters.

EDUCATION

  • 10/1997-07/2000 - Bachelor's degree BA (Business Administration with specialization in Information Technologies) at the Interdisciplinary Center Herzliya.

Screenshot_20230115_145641_WhatsApp.jpg
bottom of page